# Bioavailability and Effectiveness of Transdermally Administered Morphine

> **NCT00125684** · PHASE1 · COMPLETED · sponsor: **Alberta Health services** · enrollment: 6 (estimated)

## Conditions studied

- Cancer
- Pain

## Interventions

- **DRUG:** morphine

## Key facts

- **NCT ID:** NCT00125684
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2007-07
- **Final completion:** 2008-07
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2012-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125684, "Bioavailability and Effectiveness of Transdermally Administered Morphine". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00125684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*